Amoebic liver abscess screening

Revision as of 21:19, 20 September 2017 by Mmir (talk | contribs) (Category)
Jump to navigation Jump to search

Liver abscess Main Page

Amoebic liver abscess Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating amoebic liver abscess from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Diagnostic Approach

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amoebic liver abscess screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amoebic liver abscess screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amoebic liver abscess screening

CDC on Amoebic liver abscess screening

Amoebic liver abscess screening in the news

Blogs on Amoebic liver abscess screening

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Amoebic liver abscess screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Entamoeba histolytica infection.

Screening

According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Entamoeba histolytica infection.